Stoke Therapeutics Inc (STOK)

EBITDA Margin

-696.74%

Quarterly · Period ending:

STOK logo

STOK EBITDA Margin

Latest reported-696.74%
STOK Quarterly EBITDA Margin (0.00% → -696.74%)
High-resolution chart · PNG

STOK ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Stoke Therapeutics Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
-696.7399%
-741.1623%
-4,103.1384%
-363.3653%
-166.7294%
72.2928%
-44.0258%
-529.0151%
-520.5341%
-612.2154%
-939.8287%
-722.6421%
1,210.923%
-426.0093%
-766.167%
-885.4733%
-753.6366%
-813.4%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.